Study in Patients With Asthma

Dey Pharma

Status and phase: Completed; Phase 2

Conditions: Asthma

Treatments: Drug: Formoterol Fumarate

Study type: Interventional

Funder types: Industry

Identifiers

NCT00215397

DL-053

Details and patient eligibility

About

The purpose of this study is to determine which dose of the investigational drug is the most safe and effective in the treatment of asthma compared to the control drug.

Sex: All

Ages: 5 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with a history of asthma

Exclusion criteria

• Current asthma exacerbation or recent asthma exacerbation, requiring hospitalization
• History of smoking
• Debilitating systemic and/or life-threatening diseases.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Double Blind